May 2026
The global biosimilar monoclonal antibody market size is projected to hit around USD 124.43 billion by 2035 from USD 16.01 billion in 2025 with a CAGR of 22.76%.
March 2026
The global biosimilars market size is exhibited at USD 40.36 billion in 2025 and is projected to hit around USD 191.29 billion by 2035, growing at a solid CAGR of 16.84%.
June 2026
The global immunology biosimilars market size was estimated at USD 11.23 billion in 2025 and is expected to hit around USD 56.39 billion by 2035, growing at a CAGR of 17.51%.
June 2026
The global psoriasis biosimilars market size is evaluated at USD 10.46 billion in 2025 and is projected to attain around USD 29.78 billion by 2035, with a CAGR of 11.03%.
March 2026
The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 610.41 billion in 2025, with a CAGR of 14.80%.